Physician profile
Cameron Kitchell
NPI 1114601267
$586.28
in general payments reported to CMS, 2019-2025
11 companies · $403 in 2025
The $403 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $183 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $155.70 | 2024-2025 | Breztri, Airsupra, Farxiga |
| Amgen INC. | $90.93 | 2024-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $73.19 | 2024-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $73.05 | 2024-2025 | Ozempic, Rybelsus |
| Corium, LLC | $51.88 | 2024-2025 | Azstarys |
| Exact Sciences Corporation | $42.01 | 2025 | Cologuard Collection Kit |
| Aytu Biopharma, INC. | $26.27 | 2024 | Karbinal |
| Kowa Pharmaceuticals America, INC. | $22.56 | 2025 | Zoryve |
| Ironshore Pharmaceuticals INC. | $19.29 | 2024 | |
| Abbvie INC. | $17.76 | 2025 | |
| Dexcom, INC. | $13.64 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Kitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.